Literature DB >> 24014215

Live birth rates and birth outcomes by diagnosis using linked cycles from the SART CORS database.

Judy E Stern1, Morton B Brown, Ethan Wantman, Suleena Kansal Kalra, Barbara Luke.   

Abstract

PURPOSE: This study uses linked cycles of assisted reproductive technology (ART) to examine cumulative live birth rates, birthweight, and length of gestation by diagnostic category.
METHODS: We studied 145,660 women with 235,985 ART cycles reported to the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System during 2004-2010. ART cycles were linked to individual women by name, date of birth, social security number, partner's name, and sequence of ART treatments. The study population included the first four autologous oocyte cycles for women with a single diagnosis of male factor, endometriosis, ovulation disorders, diminished ovarian reserve, or unexplained infertility. Live birth rates were calculated per cycle, per cycle number (1-4), and cumulatively. Birthweight and length of gestation were calculated for singleton births.
RESULTS: Within each diagnosis, live birth rates were highest in the first cycle and declined with successive cycles. Women with diminished ovarian reserve had the lowest live birth rate (cumulative rate of 28.3 %); the live birth rate for the other diagnoses were very similar (cumulative rates from 62.1 % to 65.7 %). Singleton birthweights and lengths of gestation did not differ substantially across diagnoses, ranging from 3,112 to 3,286 g and 265 to 270 days, respectively. These outcomes were comparable with national averages for singleton births in the United States (3,296 g and 271 days).
CONCLUSION: Women with the diagnosis of diminished ovarian reserve had substantially lower live birth rates. However, singleton birthweights and lengths of gestation outcomes were similar across all other diagnoses.

Entities:  

Mesh:

Year:  2013        PMID: 24014215      PMCID: PMC3879943          DOI: 10.1007/s10815-013-0092-0

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  17 in total

1.  Ovarian stimulation and low birth weight in newborns conceived through in vitro fertilization.

Authors:  Suleena Kansal Kalra; Sarah J Ratcliffe; Christos Coutifaris; Thomas Molinaro; Kurt T Barnhart
Journal:  Obstet Gynecol       Date:  2011-10       Impact factor: 7.661

2.  Cycle 1 as predictor of assisted reproductive technology treatment outcome over multiple cycles: an analysis of linked cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System online database.

Authors:  Judy E Stern; Morton B Brown; Barbara Luke; Ethan Wantman; Avi Lederman; Mark D Hornstein
Journal:  Fertil Steril       Date:  2010-07-18       Impact factor: 7.329

3.  National study of factors influencing assisted reproductive technology outcomes with male factor infertility.

Authors:  Ajay K Nangia; Barbara Luke; James F Smith; Winifred Mak; Judy E Stern
Journal:  Fertil Steril       Date:  2011-07-05       Impact factor: 7.329

4.  Elective frozen replacement cycles for all: ready for prime time?

Authors:  A Maheshwari; S Bhattacharya
Journal:  Hum Reprod       Date:  2012-11-11       Impact factor: 6.918

5.  Cumulative birth rates with linked assisted reproductive technology cycles.

Authors:  Barbara Luke; Morton B Brown; Ethan Wantman; Avi Lederman; William Gibbons; Glenn L Schattman; Rogerio A Lobo; Richard E Leach; Judy E Stern
Journal:  N Engl J Med       Date:  2012-06-28       Impact factor: 91.245

6.  Time to pregnancy and pregnancy outcome.

Authors:  Anna Axmon; Lars Hagmar
Journal:  Fertil Steril       Date:  2005-10       Impact factor: 7.329

7.  Calculating cumulative live-birth rates from linked cycles of assisted reproductive technology (ART): data from the Massachusetts SART CORS.

Authors:  Judy E Stern; Morton B Brown; Barbara Luke; Ethan Wantman; Avi Lederman; Stacey A Missmer; Mark D Hornstein
Journal:  Fertil Steril       Date:  2009-07-10       Impact factor: 7.329

8.  Diagnosis and treatment of unexplained infertility.

Authors:  Alexander Quaas; Anuja Dokras
Journal:  Rev Obstet Gynecol       Date:  2008

Review 9.  Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence.

Authors:  Jie Qiao; Huai L Feng
Journal:  Hum Reprod Update       Date:  2010-07-16       Impact factor: 15.610

10.  Ovarian reserve assessment for infertility investigation.

Authors:  Bruno Ramalho de Carvalho; David Barreira Gomes Sobrinho; Andréa Duarte Damasceno Vieira; Manoela Porto Silva Resende; Antônio César Paes Barbosa; Adelino Amaral Silva; Hitomi Miura Nakagava
Journal:  ISRN Obstet Gynecol       Date:  2012-01-26
View more
  10 in total

1.  Pregnancy, birth, and infant outcomes by maternal fertility status: the Massachusetts Outcomes Study of Assisted Reproductive Technology.

Authors:  Barbara Luke; Daksha Gopal; Howard Cabral; Judy E Stern; Hafsatou Diop
Journal:  Am J Obstet Gynecol       Date:  2017-04-08       Impact factor: 8.661

2.  Adverse pregnancy and birth outcomes associated with underlying diagnosis with and without assisted reproductive technology treatment.

Authors:  Judy E Stern; Barbara Luke; Michael Tobias; Daksha Gopal; Mark D Hornstein; Hafsatou Diop
Journal:  Fertil Steril       Date:  2015-03-23       Impact factor: 7.329

3.  Impact of endometriosis on in vitro fertilization outcomes: an evaluation of the Society for Assisted Reproductive Technologies Database.

Authors:  Suneeta Senapati; Mary D Sammel; Christopher Morse; Kurt T Barnhart
Journal:  Fertil Steril       Date:  2016-04-07       Impact factor: 7.329

4.  Adverse pregnancy, birth, and infant outcomes in twins: effects of maternal fertility status and infant gender combinations; the Massachusetts Outcomes Study of Assisted Reproductive Technology.

Authors:  Barbara Luke; Daksha Gopal; Howard Cabral; Judy E Stern; Hafsatou Diop
Journal:  Am J Obstet Gynecol       Date:  2017-04-25       Impact factor: 8.661

5.  A prediction model for live birth and multiple births within the first three cycles of assisted reproductive technology.

Authors:  Barbara Luke; Morton B Brown; Ethan Wantman; Judy E Stern; Valerie L Baker; Eric Widra; Charles C Coddington; William E Gibbons; G David Ball
Journal:  Fertil Steril       Date:  2014-06-14       Impact factor: 7.329

6.  Birth Outcomes by Infertility Diagnosis Analyses of the Massachusetts Outcomes Study of Assisted Reproductive Technologies (MOSART).

Authors:  Barbara Luke; Judy E Stern; Milton Kotelchuck; Eugene R Declercq; Bruce Cohen; Hafsatou Diop
Journal:  J Reprod Med       Date:  2015 Nov-Dec       Impact factor: 0.142

7.  Endometriosis and adverse maternal, fetal and neonatal outcomes, a systematic review and meta-analysis.

Authors:  S Lalani; A J Choudhry; B Firth; V Bacal; Mark Walker; S W Wen; S Singh; A Amath; M Hodge; I Chen
Journal:  Hum Reprod       Date:  2018-10-01       Impact factor: 6.918

8.  Association of birth weight with functional ovarian reserve during menacme estimated by serum concentration of anti-Müllerian hormone.

Authors:  Maria L S Lima; Gustavo S Romão; Heloisa Bettiol; Marco Antonio Barbieri; Rui A Ferriani; Paula A Navarro
Journal:  Sci Rep       Date:  2019-05-30       Impact factor: 4.379

9.  The chance of a live birth after assisted reproduction in women with thyroid disorders.

Authors:  Line Riis Jølving; Michael Due Larsen; Jens Fedder; Sonia Friedman; Bente Mertz Nørgård
Journal:  Clin Epidemiol       Date:  2019-08-09       Impact factor: 4.790

10.  Use of a male antioxidant nutraceutical is associated with superior live birth rates during IVF treatment.

Authors:  Kelton Tremellen; Richard Woodman; Amy Hill; Helana Shehadeh; Michelle Lane; Deirdre Zander-Fox
Journal:  Asian J Androl       Date:  2021 Jan-Feb       Impact factor: 3.285

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.